По вашему запросу найдено документов: 215

Страница 8 из 22

QSAR MODELLING OF THYMIDYLATE SYNTHASE INHIBITORS IN A SERIES OF QUINAZOLINE DERIVATIVES
Khairullina, V.R., Gerchikov, A.Ya., Lagunin, A.A., Zarudii, F.S. (2017)
, new less toxic ThS inhibitors must be sought and created. The GUSAR 2013 program was used to study
QSAR MODELLING OF THYMIDYLATE SYNTHASE INHIBITORS IN A SERIES OF QUINAZOLINE DERIVATIVES
KHAIRULLINA, V.R., GERCHIKOV, A.Y., LAGUNIN, A.A., ZARUDII, F.S. (2018)
, new less toxic ThS inhibitors must be sought and created. The GUSAR 2013 program was used to study
SYNTHESIS AND ANTI-INFLAMMATORY AND ANTIULCER ACTIVITY OF A GLYCYRRHIZIC ACID CONJUGATE WITH L-PHENYLALANINE METHYL ESTER
BALTINA, L.A., SAPOZHNIKOVA, T.A., GABDRAKHMANOVA, S.F., MAKARA, N.S., ZARUDII, F.A., KONDRATENKO, R.M. (2020)
-phenylalanine methyl ester moieties in the carbohydrate part of the glycoside was shown to form a marginally toxic
Synthesis of Glycyrrhizic Acid Conjugates with S-Benzyl-L-Cysteine and Their Antiviral Activity
Baltina, L.A ., Kondratenko, M, Baltina, A, Plyasunova, O.A. (2021)
mu g/mL, SI 90) and is 50 - 55 times less toxic to cells than azidothymidine.
Synthesis and Antitumor Activity of Hybrid Compounds Based on Aryl-Substituted Isatins and 2-Chloroethynyl (4-(Dimetylamino)phenyl)(2-hydrazinyl-2-oxoethyl)phosphinate
Bogdanov, A.V., Ivanova, A.A., Voloshina, A.D., Rakhmatullin, R.R., Samorodov, A.V., Valiullina, Z.A., Krylova, I.D., Bukharov, S.V. (2024)
) and cervical epithelioid carcinoma (M-HeLa) cell lines with low toxicity towards erythrocytes and normal human
Prospects for breast cancer immunotherapy using microRNAs and transposable elements as objects
Mustafin, Rustam Nailevich (2024)
. The possibility of combining this method with chemotherapy is limited by an increased risk of toxic liver damage
Синтез и антидепрессивная активность 4-алкил-5-бром-2,4-дигидро-2- (тиетан-3-YL) -1,2,4-триазол-3-онов
Synthesis and Antidepressant Activity of 4-Alkyl-5-Bromo-2,4-Dihydro-2-(Thietan-3-YL)-1,2,4-Triazol-3-Ones
Khaliullin, F.A., Nikitina, I.L., Klen, E.E., Miftakhova, A.F., Makarova, N.N., Gabidullin, R.A., Gilmanova, A.G., Халиуллин, Ф.А., Никитина, И.Л., Клен, Э., Мифтахова, А.Ф., Макарова, Н. Н., Габидуллин, Р.А., Гильманова, А.Г. (2021)
Мини-инвазивные способы лечения доброкачественных узлов щитовидной железы
Minimally Invasive Treatment of Benign Thyroid Nodules
Г. Т. Гумерова, G. T. Gumerova, Г. М. Губайдуллина, G. M. Gubaidullina, Ф. Р. Нагаев, F. R. Nagaev, Р. Р. Бакиев, R. R. Bakiev, Н. С. Сулейманова, N. S. Suleymanova (Креативная хирургия и онкология, №1, 2022)
Безопасность применения противоопухолевых лекарственных препаратов вне зарегистрированных показаний у пациентов в реальной клинической практике: опыт онкологов субъекта Российской Федерации
Safety of the Off-Label Use of Antitumor Drugs in Real Clinical Practice: Experience of Oncologists of the Russian Federation
Е. В. Карабина, E. V. Каrabina, Д. Д. Сакаева, D. D. Sakaeva, О. Н. Липатов, O. N. Lipatov (Креативная хирургия и онкология, №4, 2024)
BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY FOR STAGE III OR IV HODGKIN'S LYMPHOMA
CONNORS, J.M., SAVAGE, K.J, JURCZAK, W, LECH-MARANDA, E., SMOLEWSKI, P, WALEWSKI, J, STRAUS, D.J., YOUNES, A., ANSELL, S.M., KIM, W.S., GALLAMINI, A., ALEKSEEV, S., ILLÉS, A., ROSTA, A., PICARDI, M., ZINZANI, P.L., OKI, Y., FELDMAN, T., BARTLETT, N.L., CHEN, R., RAMCHANDREN, R., CUNNINGHAM, D., RADFORD, J., JOSEPHSON, N.C., SONG, E., SACHS, J., JOLIN, H.A., HUEBNER, D., LIU, R., LIPATOV, O.N. (2018)
. Pulmonary toxicity of grade 3 or higher was reported in less than 1% of patients receiving A+AVD and in 3

Страница 8 из 22

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год